Evidence map›Paper›PMID 35947282›Full record

ArticlePrevention science : the official journal of the Society for Prevention Research2023

Economic Evaluation Design within the HEAL Prevention Cooperative.

Laura J Dunlap, Margaret R Kuklinski, Alexander Cowell, Kathryn E McCollister, Diana M Bowser, Mark Campbell, Claudia-Santi F Fernandes, Pranav Kemburu, Bethany J Livingston, Lisa A Prosser and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Prevention science : the official journal of the Society for Prevention Research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies.Expert review of pharmacoeconomics & outcomes research · 2024
    Review
  7. Article
  8. Article
  9. Leveraging the Full Continuum of Care to Prevent Opioid Use Disorder.Prevention science : the official journal of the Society for Prevention Research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 12 institutions in 1 country.

Laura J DunlapRTI International, E. Cornwallis Rd, PO Box 12194, Research Triangle Park, NC, 27709-2194, USA. ljd@rti.org.ORCID 0000-0002-6413-1590
Margaret R KuklinskiUniversity of Washington, Seattle, WA, USA.
Alexander CowellThe University of North Carolina at Chapel Hill, School of Government of Chapel Hill, NC, USA.
Kathryn E McCollisterSoffer Clinical Research Center, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Diana M BowserHeller School for Social Policy and Management, Brandeis University, Waltham, MA, USA.
Mark CampbellOregon Social Learning Center, Eugene, OR, USA.
Claudia-Santi F FernandesYale School of Medicine, New Haven, CT, USA.
Pranav KemburuRTI International, E. Cornwallis Rd, PO Box 12194, Research Triangle Park, NC, 27709-2194, USA.
Bethany J LivingstonEmory University School of Public Health, Atlanta, GA, USA.
Lisa A ProsserDepartment of Health Management and Policy, University of Michigan, Ann Arbor, MI, USA.
Vinod RaoDepartment of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Rosanna SmartRAND Corporation, Santa Monica, CA, USA.
Tansel YilmazerDepartment of Human Sciences, College of Education and Human Ecology, The Ohio State University, Columbus, OH, USA.
RTI International · USBrandeis University · USEmory University · USMassachusetts General Hospital · USOregon Social Learning Center · USRAND Corporation · USThe Ohio State University · USUniversity of Miami · USUniversity of Michigan · USUniversity of North Carolina at Chapel Hill · USUniversity of Washington · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Institutional Career Development CoreKL2TR001862 · NCATS · YALE UNIVERSITY · PI CANTLEY, LLOYD G, EDELMAN, E. JENNIFER · 2016 to 2025
$12.2M
HEAL Initiative: Coordinating Center to Support NIDA Preventing Opioid Use Disorder in Older Adolescents and Young AdultsU24DA050182 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI GRAHAM, PHILLIP W · 2019 to 2025
$11.6M
Supplement to HOME Trial: Role of Justice Involvement in Implementation and Effectiveness of Housing First for Youth Experiencing HomelessnessUH3DA050174 · NIDA · OHIO STATE UNIVERSITY · PI KELLEHER, KELLY J, SLESNICK, NATASHA · 2020 to 2023
$6.0M
Optimized Interventions to Prevent Opioid Use Disorder among Adolescents and Young Adults in the Emergency DepartmentUH3DA050173 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BONAR, ERIN E., WALTON, MAUREEN A · 2020 to 2021
$5.8M
Development and Implementation of a Culturally Centered Opioid Prevention Intervention for American Indian/Alaska Native Young Adults in CaliforniaUH3DA050235 · NIDA · RAND CORPORATION · PI D'AMICO, ELIZABETH J., DICKERSON, DANIEL LEE · 2020 to 2023
$5.3M
Preventing Parental Opioid and/or Methamphetamine Addiction within DHS-Involved Families: FAIRUH3DA050193 · NIDA · OREGON SOCIAL LEARNING CENTER, INC. · PI SALDANA, LISA · 2020 to 2020
$5.1M
Community Randomized Trial in the Cherokee Nation: CONNECT and CMCA for Preventing Drug Misuse among Older AdolescentsUH3DA050234 · NIDA · EMORY UNIVERSITY · PI KOMRO, KELLI ANN, LIVINGSTON, MELVIN D · 2020 to 2023
$4.9M
Preventing Opioid Use Among Justice-Involved Youth as They Transition to Adulthood: Leveraging Safe Adults (LeSA)UH3DA050250 · NIDA · TEXAS CHRISTIAN UNIVERSITY · PI KNIGHT, DANICA K · 2020 to 2020
$4.5M
The Role of Family Functioning and Race/Ethnicity on the Efficacy of an Opioid Misuse Prevention Videogame Intervention for AdolescentsUH3DA050251 · NIDA · YALE UNIVERSITY · PI FIELLIN, LYNN ELIZABETH · 2021 to 2021
$4.4M
Using SMART Design to Identify an Effective and Cost-Beneficial Approach to Preventing OUD in Justice-Involved YouthUH3DA050189 · NIDA · SEATTLE CHILDREN'S HOSPITAL · PI AHRENS, KYM R, HAGGERTY, KEVIN P · 2021 to 2023
$4.1M
Does Treating Young Persons Psychopathology Prevent the Onset of Opioid and other Substance Use Disorders?UH3DA050252 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI WILENS, TIMOTHY E, YULE, AMY · 2020 to 2020
$3.0M
NCATS NIH HHS KL2 TR001862NCATS NIH HHS UL1 TR001863NIDA NIH HHS U24 DA050182NIDA NIH HHS U24DA050182NIDA NIH HHS UG3 DA050189NIDA NIH HHS UG3 DA050234NIDA NIH HHS UH3 DA050173NIDA NIH HHS UH3DA050173NIDA NIH HHS UH3 DA050174NIDA NIH HHS UH3DA050174NIDA NIH HHS UH3 DA050189NIDA NIH HHS UH3DA050189NIDA NIH HHS UH3 DA050193NIDA NIH HHS UH3DA050193NIDA NIH HHS UH3 DA050234NIDA NIH HHS UH3DA050234NIDA NIH HHS UH3 DA050235NIDA NIH HHS UH3DA050235NIDA NIH HHS UH3 DA050250NIDA NIH HHS UH3DA050250NIDA NIH HHS UH3 DA050251NIDA NIH HHS UH3DA050251NIDA NIH HHS UH3 DA050252NIDA NIH HHS UH3DA050252
6 · The paper itself

Abstract

The rapid rise in opioid misuse, disorder, and opioid-involved deaths among older adolescents and young adults is an urgent public health problem. Prevention is a vital part of the nation's response to the opioid crisis, yet preventive interventions for those at risk for opioid misuse and opioid use disorder are scarce. In 2019, the National Institutes of Health (NIH) launched the Preventing Opioid Use Disorder in Older Adolescents and Young Adults cooperative as part of its broader Helping to End Addiction Long-term (HEAL) Initiative ( https://heal.nih.gov/ ). The HEAL Prevention Cooperative (HPC) includes ten research projects funded with the goal of developing effective prevention interventions across various settings (e.g., community, health care, juvenile justice, school) for older adolescent and young adults at risk for opioid misuse and opioid use disorder (OUD). An important component of the HPC is the inclusion of an economic evaluation by nine of these research projects that will provide information on the costs, cost-effectiveness, and sustainability of these interventions. The HPC economic evaluation is integrated into each research project's overall design with start-up costs and ongoing delivery costs collected prospectively using an activity-based costing approach. The primary objectives of the economic evaluation are to estimate the intervention implementation costs to providers, estimate the cost-effectiveness of each intervention for reducing opioid misuse initiation and escalation among youth, and use simulation modeling to estimate the budget impact of broader implementation of the interventions within the various settings over multiple years. The HPC offers an extraordinary opportunity to generate economic evidence for substance use prevention programming, providing policy makers and providers with critical information on the investments needed to start-up prevention interventions, as well as the cost-effectiveness of these interventions relative to alternatives. These data will help demonstrate the valuable role that prevention can play in combating the opioid crisis.

Indexed as

Behavior, AddictiveOpioid-Related DisordersAdolescentAnalgesics, OpioidCost-Benefit AnalysisHumansYoung AdultAnalgesics, OpioidBudget impact analysisCost-effectivenessHEAL Prevention CooperativeHelping to End Addiction Long-term (HEAL)Older adolescents and young adultsOpioid misuseOpioid use disorder

Identifiers

PMID35947282
PMCPMC9364296
OpenAlexW4291708512

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.